Crinone: Clinical Trials

18 trials of Crinone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 withdrawn, 1 terminated, 1 unknown. 7 Phase 4, 6 Phase 3, 3 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 47Completed 4, Terminated 1, Unknown 1, Withdrawn 1
Phase 36Completed 5, Withdrawn 1
Not applicable3Completed 3
Phase 22Completed 2

Follow Crinone: new trials by email Literature Review of Crinone trials Research Report on Crinone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
Progesterone-IBSA Injectable Solution, Progesterone Vaginal Gel with Applicator, Placebo Vaginal gel with applicator - Infertility
Phase 3CompletedIBSA Institut Biochimique SA6882022-10-122026-08-27
Luteal Support in Frozen-Thawed Embryo Transfer Cycles
Dydrogesterone 10Mg Tablet (duphaston), Progesterone 50Mg/mL Oil, Crinone 8% Vaginal Gel - Implantation; Placenta, Pregnancy Loss
Phase 4CompletedCentrum Clinic IVF Center1512021-06-302022-01-11
Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)
Crinone, Duphaston - Infertility
Phase 4TerminatedMerck KGaA, Darmstadt, Germany1722019-05-312024-03-12
Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles
Dydrogesterone 10 MG Oral Tablet, Progesterone Vaginal Gel [Crinone] - Infertility, Female, Infertility, Male
Phase 4UnknownMemorial Sisli Hospital, Istanbul1402019-01-022019-10-14
Hormones and Reduction in Co-users of Marijuana and Nicotine
Progesterone, placebo - Marijuana Dependence
Not applicableCompletedUniversity of Minnesota582015-11-012020-06-26
A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)
Dydrogesterone 30 mg, intravaginal progesterone gel 90 mg - Female Infertility
Phase 3CompletedAbbott10342015-07-012019-10-01
An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)
MK-8962, recFSH, Ganirelix - Infertility
Phase 3WithdrawnOrganon and Co2014-03-012022-02-03
Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole
Progesterone Vaginal Gel 8%, Letrozole Oral Tablet, pelvic ultrasound - Polycystic Ovary Syndrome
Phase 2 / Phase 3CompletedEastern Virginia Medical School522012-07-062018-02-26
Intrauterine Insemination and Luteal Fase Support
crinone (progesterone 8%, vaginal application) - Infertility
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven3932011-04-012018-10-19
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
Menotrophin, Follitrophin alpha, Cetrorelix - Infertility
Phase 4CompletedFerring Pharmaceuticals1242010-10-012014-03-14
Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support
Oral dydrogesterone, Crinone 8% gel - Luteal Phase Defect
Not applicableCompletedUniversity of Zagreb8532010-10-012014-01-29
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
Ovarian stimulation in a GnRH-antagonist protocol - Infertility, Subfertility
CompletedUniversity Hospital Schleswig-Holstein2942010-09-012016-01-05
Low Molecular Weight Heparin in Recurrent Implantation Failure
low molecular weight heparin (enoxaparine sodium), crinone 8% gel - Infertility, Fertilization in Vitro
Not applicableCompletedV.K.V. American Hospital, Istanbul2006-01-012009-03-20
Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)
Endometrin, Crinone - Fertility
Phase 3CompletedFerring Pharmaceuticals12112005-07-012011-05-19
Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement
DR-2011, Progesterone 8% Vaginal Gel - Infertility
Phase 2CompletedDuramed Research202005-06-012014-05-12
Vaginal Progesterone to Reduce the Risk of Another Preterm Birth
8% progesterone vaginal gel, Placebo Vaginal Gel - Pregnancy
Phase 3CompletedJuniper Pharmaceuticals, Inc.6362004-04-012010-08-19
Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
Crinone 8% Vaginal Gel, Intramuscular Progesterone - Infertility
Phase 4CompletedBrigham and Women's Hospital4682003-07-012011-09-22
Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles
Vaginal progesterone gel (Crinone® 8%), Intramuscular Progesterone - Infertility
Phase 4WithdrawnBrigham and Women's Hospital2019-09-09

Conditions studied

Infertility (10)  ·  Infertility, Female (2)  ·  Helping Behavior (1)  ·  Infertility, Male (1)  ·  Marijuana Abuse (1)  ·  Polycystic Ovary Syndrome (1)

Sponsors

Brigham and Women's Hospital (2)  ·  Ferring Pharmaceuticals (2)  ·  Abbott (1)  ·  Centrum Clinic IVF Center (1)  ·  Duramed Research (1)  ·  Eastern Virginia Medical School (1)  ·  IBSA Institut Biochimique SA (1)  ·  Juniper Pharmaceuticals, Inc. (1)  ·  Memorial Sisli Hospital, Istanbul (1)  ·  Merck KGaA, Darmstadt, Germany (1)  ·  Organon and Co (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University Hospital Schleswig-Holstein (1)  ·  University of Minnesota (1)  ·  University of Zagreb (1)

Countries

United States (7)  ·  Germany (3)  ·  Turkey (Türkiye) (3)  ·  Belgium (2)  ·  China (2)  ·  Australia (1)  ·  Croatia (1)  ·  Hong Kong (1)  ·  India (1)  ·  Norway (1)  ·  Russia (1)  ·  Singapore (1)  ·  Thailand (1)  ·  Ukraine (1)

Top investigators

Cumhur B Urman, M.D. (1)  ·  Elena H Yanushpolsky, M.D. (1)  ·  Elena Yanushpolsky, MD (1)  ·  Emre Pabuccu, Assoc. Prof. (1)  ·  George W Creasy, MD (1)  ·  Jozo Tomic, M.D. (1)  ·  Laurel A Stadtmauer, MD, PhD (1)  ·  Semra Kahraman, Prof (1)  ·  Sharon Allen, Ph.D,M.D. (1)  ·  Shreyansh Shah, MD (1)  ·  Vlatka Tomic, M.D. (1)

Results publications

PMID 30304457, PMID 17899571, PMID 17899572, PMID 19357135, PMID 19918965, PMID 20347079, PMID 25622239, PMID 27565253, PMID 27761732, PMID 29338855